Outstanding Half-Year Results
Results for the first half of 2010 significantly exceeded target and represented an increase in revenue of over 100% compared to the previous period in 2009. In addition to a number of classical pharma and biotech companies, clients also included one medical device company, one company active in the field of regenerative medicine, one drug-delivery company and a number of companies who themselves see pharma and biotech as their clients. Three interim assignments transitioned into permanent appointments and two Interim Managers were placed in Germany. As is typical with Interea, the assignments encompassed a wide range of functions including, Finance, Supply Chain, Marketing, Regulatory Affairs, Quality Assurance and Business Development.
> Click here to view other assignments
